About
Allografts
Areas of Focus
Categories
Biologics & BiopharmaceuticalWound HealingSouthwestern U.S.
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
11
As Collaborator
0
Total Enrollment
1,120
By Phase
PHASE2: 3PHASE1/PHASE2: 3PHASE1: 2PHASE3: 1
By Status
WITHDRAWN: 3TERMINATED: 3RECRUITING: 2NO_LONGER_AVAILABLE: 2COMPLETED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06918808Lead Sponsor
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
PHASE2Recruiting
36 participants
Started: May 19, 2025 · Completed: Oct 31, 2026
NCT05127122Lead Sponsor
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDS
PHASE1/PHASE2Withdrawn
Started: Dec 31, 2024 · Completed: Dec 31, 2024
NCT05116761Lead Sponsor
ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 Syndrome
PHASE1/PHASE2Withdrawn
Started: Nov 30, 2024 · Completed: Dec 31, 2024
NCT05836883Lead Sponsor
Study of ExoFlo for the Treatment of Perianal Fistulas
PHASE1/PHASE2Terminated
5 participants
Started: Aug 28, 2023 · Completed: Dec 1, 2024
NCT05130983Lead Sponsor
Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease
PHASE1Terminated
3 participants
Started: Jan 23, 2023 · Completed: Dec 1, 2024
Funding History (1)
D
Dec 13, 2022
Locations (1)
Headquarters
Austin, TX, United States
Map
Loading map...